Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats

Pain

Volumn 153, Issue 11, 2012, Pages 2283-2291

  Niu, Katelyn Y ^a   Zhang, Youping ^a   Ro, Jin Y ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Estrogen; IL 1 ; IL 6; Masseter muscle; Testosterone; Trigeminal ganglia

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ARACHIDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; ESTRADIOL; FREUND ADJUVANT; INTERLEUKIN 1BETA; INTERLEUKIN 6; SEX HORMONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; MALE; MASSETER MUSCLE; MYOSITIS; NONHUMAN; OROFACIAL MYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; UPREGULATION;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGENS; FACIAL PAIN; FEMALE; MALE; MYOSITIS; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; TESTOSTERONE;

EID: 84867580940     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.07.037     Document Type: Article

References (61)

1. N. Agarwal, P. Pacher, I. Tegeder, F. Amaya, C.E. Constantin, G.J. Brenner, T. Rubino, C.W. Michalski, G. Marsicano, K. Monory, K. Mackie, C. Marian, S. Batkai, D. Parolaro, M.J. Fischer, P. Reeh, G. Kunos, M. Kress, B. Lutz, C.J. Woolf, and R. Kuner Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors Nat Neurosci 10 2007 870 879
2. J. Ahluwalia, L. Urban, M. Capogna, S. Bevan, and I. Nagy Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons Neuroscience 100 2000 685 688
3. A.M. Aloisi, I. Ceccarelli, M. Carlucci, A. Suman, G. Sindaco, S. Mameli, V. Paci, L. Ravaioli, G. Passavanti, V. Bachiocco, and G. Pari Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients Reprod Biol Endocrinol 9 2011 26
4. F. Amaya, G. Shimosato, Y. Kawasaki, S. Hashimoto, Y. Tanaka, R.R. Ji, and M. Tanaka Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist PAIN® 124 2006 175 183
5. R. Ambalavanar, A. Moutanni, and D. Dessem Inflammation of craniofacial muscle induces widespread mechanical allodynia Neurosci Lett 399 2006 249 254
6. D.R. Blake, P. Robson, M. Ho, R.W. Jubb, and C.S. McCabe Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis Rheumatology (Oxford) 45 2006 50 52
7. C. Börner, V. Höllt, and J. Kraus Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene Mol Pharmacol 61 2002 800 805
8. C. Börner, J. Kraus, H. Schröder, H. Ammer, and V. Höllt Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6 Mol Pharmacol 66 2004 1719 1726
9. H.B. Bradshaw, N. Rimmerman, J.F. Krey, and J.M. Walker Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators Am J Physiol Regul Integr Comp Physiol 291 2006 R349 R358
10. M. Brusberg, S. Arvidsson, D. Kang, H. Larsson, E. Lindström, and V. Martinez CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents J Neurosci 29 2009 1554 1564
11. J.J. Burston, J.L. Wiley, A.A. Craig, D.E. Selley, and L.J. Sim-Selley Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure Br J Pharmacol 161 2010 103 112
12. L. Busch, L. Sterin-Borda, and E. Borda Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland Clin Exp Pharmacol Physiol 33 2006 258 263
13. C.M. Cahill, and J.T. Rogers Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1 J Biol Chem 283 2008 25900 25912
14. B. Chen, S. Tsui, and T.J. Smith IL-1 beta induces IL-6 expression in human orbital fibroblasts: identification of an anatomic-site specific phenotypic attribute relevant to thyroid-associated ophthalmopathy J Immunol 175 2005 1310 1319
15. R.A. Cohn, P.R. Barnes, E. Barratt, and J.H. Pirch Sex differences in response to marijuana in the cat J.M. Singh, L.H. Miller, H. Lal, Drug addiction experimental pharmacology Vol. 1 1972 Futura New York 227 234
16. E.K. Dziadulewicz, S.J. Bevan, C.T. Brain, P.R. Coote, A.J. Culshaw, A.J. Davis, L.J. Edwards, A.J. Fisher, A.J. Fox, C. Gentry, A. Groarke, T.W. Hart, W. Huber, I.F. James, A. Kesingland, L. La Vecchia, Y. Loong, I. Lyothier, K. McNair, C. O'Farrell, M. Peacock, R. Portmann, U. Schopfer, M. Yaqoob, and J. Zadrobilek Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration J Med Chem 50 2007 3851 3856
17. H.E. Gibson, J.G. Edwards, R.S. Page, M.J. Van Hook, and J.A. Kauer TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons Neuron 57 2008 746 759
18. S. González, T. Bisogno, T. Wenger, J. Manzanares, A. Milone, F. Berrendero, V. Di Marzo, J.A. Ramos, and J.J. Fernández-Ruiz Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland Biochem Biophys Res Commun 270 2000 260 266
19. A.V. Guerrero, P. Quang, N. Dekker, R.C. Jordan, and B.L. Schmidt Peripheral cannabinoids attenuate carcinoma-induced nociception in mice Neurosci Lett 433 2008 77 81
20. T. Gutierrez, J.N. Farthing, A.M. Zvonok, A. Makriyannis, and A.G. Hohmann Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis Br J Pharmacol 150 2007 153 163
21. T. Hayase, Y. Yamamoto, and K. Yamamoto Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity Nihon Arukoru Yakubutsu Igakkai Zasshi 36 2001 596 608
22. A. Hazekamp, and F. Grotenhermen Review on clinical studies with cannabis and cannabinoids 2005-2009 Cannabinoids 5 2010 1 21
23. M.A. Hook, S.N. Washburn, G. Moreno, S.A. Woller, D. Puga, K.H. Lee, and J.W. Grau An IL-1 receptor antagonist blocks a morphine-induced attenuation of locomotor recovery after spinal cord injury Brain Behav Immun 25 2011 349 359
24. 2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats Br J Pharmacol 162 2011 428 440
25. H. Imbe, R. Dubner, and K. Ren Masseteric inflammation-induced Fos protein expression in the trigeminal interpolaris/caudalis transition zone: contribution of somatosensory-vagal-adrenal integration Brain Res 845 1999 165 175
26. L. Jean-Gilles, B. Gran, and C.S. Constantinescu Interaction between cytokines, cannabinoids and the nervous system Immunobiology 215 2010 606 610
27. L.M. Johanek, and D.A. Simone Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury PAIN® 109 2004 432 442
28. S.W. Kauma, T.T. Turner, and J.R. Harty Interleukin-1 beta stimulates interleukin-6 production in placental villous core mesenchymal cells Endocrinology 134 1994 457 460
29. S. Kelly, M.D. Jhaveri, D.R. Sagar, D.A. Kendall, and V. Chapman Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation Eur J Neurosci 18 2003 2239 2243
30. I.A. Khasabova, S.G. Khasabov, C. Harding-Rose, L.G. Coicou, B.A. Seybold, A.E. Lindberg, C.D. Steevens, D.A. Simone, and V.S. Seybold A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain J Neurosci 28 2008 11141 11152
31. B. Kraft, N.A. Frickey, R.M. Kaufmann, M. Reif, R. Frey, B. Gustorff, and H.G. Kress Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers Anesthesiology 109 2008 101 110
32. J. Kraus, C. Börner, E. Giannini, and V. Höllt The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene Mol Pharmacol 64 2003 876 884
33. R. Kuhweide, J. Van Damme, and J.L. Ceuppens Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth Eur J Immunol 20 1990 1019 1025
34. F. Loría, S. Petrosino, L. Mestre, A. Spagnolo, F. Correa, M. Hernangómez, C. Guaza, V. Di Marzo, and F. Docagne Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide Eur J Neurosci 28 2008 633 641
35. B. Mateos, E. Borcel, R. Loriga, W. Luesu, V. Bini, R. Llorente, M.P. Castelli, and M.P. Viveros Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors J Psychopharmacol 25 2011 1676 1690
36. S. Mitrirattanakul, N. Ramakul, A.V. Guerrero, Y. Matsuka, T. Ono, H. Iwase, K. Mackie, K.F. Faull, and I. Spigelman Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain PAIN® 126 2006 102 114
37. A.G. Nackley, R.L. Suplita 2nd, and A.G. Hohmann A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 117 2003 659 670
38. K.Y. Niu, and J.Y. Ro Changes in intramuscular cytokine levels during masseter inflammation in male and female rats Neurosci Lett 487 2011 223 227
39. M. Notarnicola, C. Messa, A. Orlando, M. Bifulco, C. Laezza, P. Gazzerro, and M.G. Caruso Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines Scand J Gastroenterol 43 2008 66 72
40. T.J. Nurmikko, M.G. Serpell, B. Hoggart, P.J. Toomey, B.J. Morlion, and D. Haines Sativex successfully treats neuropathic pain characterised by allodynia: a randomised, double-blind, placebo-controlled clinical trial PAIN® 133 2007 210 220
41. O. Obreja, M. Schmelz, S. Poole, and M. Kress Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo PAIN® 96 2002 57 62
42. G. Poli, P. Bressler, A. Kinter, E. Duh, W.C. Timmer, A. Rabson, J.S. Justement, S. Stanley, and A.S. Fauci Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms J Exp Med 172 1990 151 158
43. C. Potenzieri, C. Harding-Rose, and D.A. Simone The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms Brain Res 1215 2008 69 75
44. W. Puehler, H.L. Rittner, S.A. Mousa, A. Brack, H. Krause, C. Stein, and M. Schäfer Interleukin-1 beta contributes to the upregulation of kappa opioid receptor mrna in dorsal root ganglia in response to peripheral inflammation Neuroscience 141 2006 989 998
45. W.J. Redmond, P. Goffaux, S. Potvin, and S. Marchand Analgesic and antihyperalgesic effects of nabilone on experimental heat pain Curr Med Res Opin 24 2008 1017 1024
46. G.M. Reis, M.A. Ramos, F. Pacheco Dda, A. Klein, A.C. Perez, and I.D. Duarte Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels Life Sci 88 2011 653 657
47. K. Ren An improved method for assessing mechanical allodynia in the rat Physiol Behav 67 1999 711 716
48. J.D. Richardson, S. Kilo, and K.M. Hargreaves Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors PAIN® 75 1998 111 119
49. C.J. Riebe, M.N. Hill, T.T. Lee, C.J. Hillard, and B.B. Gorzalka Estrogenic regulation of limbic cannabinoid receptor binding Psychoneuroendocrinology 35 2010 1265 1269
50. T. Rubino, and D. Parolaro Sexually dimorphic effects of cannabinoid compounds on emotion and cognition Front Behav Neurosci 5 2011 64
51. B.B. Ruzicka, R.C. Thompson, S.J. Watson, and H. Akil Interleukin-1 beta-mediated regulation of mu-opioid receptor mRNA in primary astrocyte-enriched cultures J Neurochem 66 1996 425 428
52. E. Sánchez, A. Bagües, and M. Martin Cannabinoids and muscular pain. Effectiveness of the local administration in rat Eur J Pain 2012 10.1002/j.1532-2149.2012.00115.x [Epub ahead of print]
53. T.D. Schmittgen, and K.J. Livak Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 2008 1101 1108
54. K. Shimizu, W. Guo, H. Wang, S. Zou, S.C. LaGraize, K. Iwata, F. Wei, R. Dubner, and K. Ren Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors Mol Pain 21 2009 75
55. A.H. Tseng, and R.M. Craft Sex differences in antinociceptive and motoric effects of cannabinoids Eur J Pharmacol 430 2001 41 47
56. A.H. Tseng, and R.M. Craft CB(1) receptor mediation of cannabinoid behavioral effects in male and female rats Psychopharmacology (Berl) 172 2004 25 30
57. A.H. Tseng, J.W. Harding, and R.M. Craft Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats Behav Brain Res 154 2004 77 83
58. E.L. Vidal, N.A. Patel, G. Wu, M. Fiala, and S.L. Chang Interleukin-1 induces the expression of mu opioid receptors in endothelial cells Immunopharmacology 38 1998 261 266
59. 1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents Mol Pain 7 2011 31
60. X. Wang, R.J. Traub, and A.Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regul Integr Comp Physiol 291 2006 R300 R306
61. X.H. Yu, C.Q. Cao, G. Martino, C. Puma, A. Morinville, S. St-Onge, E. Lessard, M.N. Perkins, and J.M. Laird A peripherally restricted cannabinoid receptor agonist produces robust anti-nociceptive effects in rodent models of inflammatory and neuropathic pain PAIN® 151 2010 337 344